Rathbones Group Analysis: Insights on Balanced Commercial Property Trust
Key Disclosure Information
8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser: Rathbones Group Plc
(c) Name of offeror/offeree: Balanced Commercial Property Trust Limited
(e) Date position held: The latest practicable date prior to the disclosure.
04/10/2024
(f) In addition to the company in 1(c), is the discloser making disclosures in respect of any other party to the offer?No
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are more positions to disclose, copy table 2(a) or (b) accordingly.
(a) Interests and short positions in the relevant securities:
Class of relevant security: 1p Ord
Relevant securities owned and/or controlled:
20,411,115 (2.90%)
TOTAL: 20,411,115 (2.90%)
All interests and all short positions must be disclosed.
(b) Rights to subscribe for new securities: None disclosed.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(a) Purchases and sales
1p Ordinary Shares
Sale, Number of securities: 3,500, Price per unit: 95.125p
1p Ordinary Shares
Sale, Number of securities: 48,484, Price per unit: 95.15p
(b) Cash-settled derivative transactions None.
(ii) Exercise None.
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements: None disclosed.
(b) Agreements relating to options or derivatives: None disclosed.
(c) Attachments: No supplemental form attached.
Date of disclosure: 07/10/2024
Contact name: Chinwe Enyi - Compliance Department
Telephone number: 0151 243 7053
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel’s Market Surveillance Unit is available for consultation regarding the Code’s disclosure requirements.
Frequently Asked Questions
What is Rathbones Group Plc?
Rathbones Group Plc is a wealth management firm in the United Kingdom, dedicated to managing client investments and offering private banking services.
What is Balanced Commercial Property Trust Limited?
Balanced Commercial Property Trust Limited is an investment trust focusing on a diversified portfolio of commercial properties, allowing investors exposure to real estate market opportunities.
What significance does a 2.90% holding indicate?
A 2.90% holding shows Rathbones Group has a noteworthy position in Balanced Commercial Property Trust, highlighting their confidence in the trust’s investment strategy.
How often are these disclosures made?
Disclosures such as these are typically mandated by regulations and must be promptly reported whenever significant positions or changes occur.
Where can I find more information about stock dealings?
Investors can often find detailed disclosures and related information through regulatory filings or financial news platforms, where market transparency is encouraged.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Caesars Entertainment Unveils Horseshoe Online Casino in Michigan
- Analyzing Boston Scientific's Position Among Industry Leaders
- Discover Keysight's Innovations at India Mobile Congress 2024
- NEAR Protocol Surges Over 5% Amid Market Fluctuations
- Quectel Enhances IoT Connectivity with New Modules for Efficiency
- Snowflake's Options Activity: Insights from Recent Trends
- Exploring NVIDIA's Options Trading Insights and Trends
- Gilead Sciences Unveils Groundbreaking Data on HIV Prevention
- Shooter Training Revolution: Shoot-A-Way's Decision Mode Launch
- Understanding Taiwan Semiconductor's Options Trend and Insights
Recent Articles
- Supporting Local Artists: The Record Co.'s AMPLIFY BOSTON Campaign
- LightBox CRE Activity Index Sees Positive Response to Rates
- Sibelco's Commitment: $1 Million Donation and Foundation Launch
- Trulieve Launches New Dispensary, Enhancing Patient Access
- Softchoice to Reveal Third Quarter 2024 Financials Soon
- Investors Can Lead a Class Action Against Bumble Inc. BMBL
- Elevance Health Upcoming Call Highlights Q3 2024 Financials
- Power Metals Corp. Reports Significant Cesium Findings
- Understanding Barnes Group Inc.'s Shareholder Rights and Concerns
- Concerns Rise Over Duckhorn Portfolio's Shareholder Value
- IceCure's ProSense® Shines in Global Breast Imaging Studies
- Innovation Beverage Group Announces New CSO Genevieve Jodhan
- Haoxi Health Technology Limited Projects Impressive Revenue Growth
- Diversified Healthcare Trust Conference Call Highlights and Details
- Trex Company Sets Date for Q3 Earnings Call Announcement
- Upcoming Earnings Announcement from Flexsteel Industries, Inc.
- Deckers Outdoor Faces Downgrade but Shows Promising Growth Ahead
- A10 Networks Set to Unveil Q3 2024 Financial Performance Details
- NIP Group Welcomes New Director Randy Hearst Harris
- IceCure Medical Showcases ProSense® Breakthroughs at EUSOBI
- Revvity's Upcoming Earnings Call Promises Insight for Investors
- Akoya Biosciences' Role in Advancing Cancer Research Efforts
- Fortune Minerals Collaborates with Worley for NICO Project Enhancement
- Worksport Sets Ambitious Goals with New Product Launches
- Freedman Normand Friedland Enhances Legal Services in Art Law
- Ultragenyx's Setrusumab Receives FDA Breakthrough Therapy Nod
- MG Digital Direct Enhances Marketing with Advanced Solutions
- Commercial Real Estate Sees Renewed Interest Following Rate Cuts
- CDK Global Deepens Ties with AutoCanada, Enhancing Dealerships
- Eternity Technology Partners with Connexa for AI Innovations
- Exiger Partners with AHA to Strengthen Cybersecurity in Healthcare
- Vapor IO Launches Innovative AI-Powered 5G Network in Las Vegas
- Mizuho Adjusts CVR Energy Price Target Amid Market Challenges
- Barclays Upgrades Global Payments Rating Amid Growth Strategy
- Tour24 and Brivo Team Up for Enhanced Self-Guided Tours
- Rivian's Path Ahead: Challenges and Growth Opportunities
- Subway Canada and Scottie Barnes Team Up for Epic Carnivore Sub
- AngioDynamics Updates Buy Rating and Targets Despite Sales Decline
- Acrylic Tooth Market Growth Poised for Bright Future Ahead
- Empowering Marketing: Horizon Media’s AI Partnership with Akkio
- Trinity Biotech's Glucose Monitor Shows Promising Clinical Results
- GreenFirst Revisions Share Capital and Implements Consolidation
- Revolutionizing Golf Performance: Newton GOLF's New Shafts
- Ocean Power Technologies Sets New Standard with AI PowerBuoy Shipment
- Okta Unveils Finalists for Innovative Identity Security Pitch
- Discovering High-Grade Ionic Absorption Clays: Verde's Progress
- Wolters Kluwer Enhances Collaboration with CalCPA for BOI Compliance
- Top 3 Stocks for Reliable Dividends and Income Growth
- Ultragenyx's Setrusumab Gains FDA Breakthrough Therapy Status
- FICO Achieves Leader Status in IDC MarketScape Report 2024